- Browse by Subject
Browsing by Subject "Single Nucleotide Variants (SNVs)"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2(Frontiers Media, 2020-09-25) Liu, Sheng; Shen, Jikui; Fang, Shuyi; Li, Kailing; Liu, Juli; Yang, Lei; Hu, Chang-Deng; Wan, Jun; Medical and Molecular Genetics, School of MedicineFour signature groups of frequently occurred single-nucleotide variants (SNVs) were identified in over twenty-eight thousand high-quality and high-coverage SARS-CoV-2 complete genome sequences, representing different viral strains. Some SNVs predominated but were mutually exclusively presented in patients from different countries and areas. These major SNV signatures exhibited distinguishable evolution patterns over time. A few hundred patients were detected with multiple viral strain-representing mutations simultaneously, which may stand for possible co-infection or potential homogenous recombination of SARS-CoV-2 in environment or within the viral host. Interestingly nucleotide substitutions among SARS-CoV-2 genomes tended to switch between bat RaTG13 coronavirus sequence and Wuhan-Hu-1 genome, indicating the higher genetic instability or tolerance of mutations on those sites or suggesting that major viral strains might exist between Wuhan-Hu-1 and RaTG13 coronavirus.Item GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences(Oxford University Press, 2020-10-12) Fang, Shuyi; Li, Kailing; Shen, Jikui; Liu, Sheng; Liu, Juli; Yang, Lei; Hu, Chang-Deng; Wan, Jun; BioHealth Informatics, School of Informatics and ComputingThe COVID-19 outbreak has become a global emergency since December 2019. Analysis of SARS-CoV-2 sequences can uncover single nucleotide variants (SNVs) and corresponding evolution patterns. The Global Evaluation of SARS-CoV-2/hCoV-19 Sequences (GESS, https://wan-bioinfo.shinyapps.io/GESS/) is a resource to provide comprehensive analysis results based on tens of thousands of high-coverage and high-quality SARS-CoV-2 complete genomes. The database allows user to browse, search and download SNVs at any individual or multiple SARS-CoV-2 genomic positions, or within a chosen genomic region or protein, or in certain country/area of interest. GESS reveals geographical distributions of SNVs around the world and across the states of USA, while exhibiting time-dependent patterns for SNV occurrences which reflect development of SARS-CoV-2 genomes. For each month, the top 100 SNVs that were firstly identified world-widely can be retrieved. GESS also explores SNVs occurring simultaneously with specific SNVs of user's interests. Furthermore, the database can be of great help to calibrate mutation rates and identify conserved genome regions. Taken together, GESS is a powerful resource and tool to monitor SARS-CoV-2 migration and evolution according to featured genomic variations. It provides potential directive information for prevalence prediction, related public health policy making, and vaccine designs.